OCI Acquires 11% Stake in Bukwang Pharm for 146.1 Billion KRW, Becomes Largest Shareholder
[Asia Economy Reporter Kwon Jae-hee] OCI announced on the 22nd that it will acquire 7,730,334 shares held by Chairman Kim Dong-yeon, the largest shareholder of Bukwang Pharm, and 9 other related parties for 146.1 billion KRW.
This corresponds to 6.12% of OCI's equity capital.
With this acquisition, OCI's shares in Bukwang Pharm will increase to 7,747,934 shares, raising its stake to 10.90%.
OCI stated, "The acquisition was made to expand our entry into the bio business."
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- Signed Without Viewing for 1.6 Billion Won... Jamsil and Seongbuk Jeonse Prices Jump 200 Million Won in a Month [Real Estate AtoZ]
- "Groups of 5 or More Now Restricted"... Unrelenting Running Craze Leaves Citizens and Police Exhausted
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
The scheduled date for the stock acquisition is March 8.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
